Prescription drug monitoring programs (PDMPs) are primary prevention tools designed to reduce rising rates of substance use disorders (SUD) and sequelae such as neonatal abstinence syndrome. Evidence regarding OB/GYN perceptions of PDMPs, which may impact PDMP utilization, is unavailable. This study examines perceived PDMP effectiveness among OB/GYNs compared to primary care physicians (PCPs).
CITATION STYLE
Goodin, A., Brown, J., Freeman, P., Henry, S., Talbert, J., & Delcher, C. (2019). Obstetrician/Gynecologist Perception of Prescription Drug Monitoring Program Effectiveness [15I]. Obstetrics & Gynecology, 133(1), 99S-99S. https://doi.org/10.1097/01.aog.0000558792.87713.72
Mendeley helps you to discover research relevant for your work.